ResearcherLiaoning Cancer Hospital & InstituteNo recent work listed
Xiangdong Hua
Matched on ORCID iD 0000-0002-4020-3908; OpenAlex author ID A5056584794. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 5
- Petite Integration Factor 1 knockdown enhances gemcitabine sensitivity in pancreatic cancer cells via increasing DNA damage. First author DOI 10.1002/jat.4494↗
- Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer. Last author DOI 10.1007/s11010-022-04404-5↗
- LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p. Co-author DOI 10.1016/j.abb.2020.108469↗
- TSPAN1 promotes human pancreatic cancer cells proliferation by modulating CDK1 via Akt Co-author DOI 10.1101/2020.05.29.123091↗
- Preliminary study of pancreatic cancer associated with Helicobacter pylori infection. First author DOI 10.1007/s12013-014-0211-2↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kun Wang · 2 shared papers, 2022–2023 · strength 0.40
- Jiaxun Tian · 2 shared papers, 2020 · strength 0.25
- Xin Wang · 2 shared papers, 2020 · strength 0.25
- Gang Shi · 2 shared papers, 2020 · strength 0.25
- Siyuan Li · 1 shared paper, 2023 · strength 0.22
- Zhaoqiang Feng · 1 shared paper, 2015 · strength 0.06
- Fulu Ai · 1 shared paper, 2015 · strength 0.06
- Yefu Liu · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.